Eesti - eesti - Ravimiamet

pharmaceutical works polpharma s.a. - olansapiin - suus dispergeeruv tablett - 15mg 56tk; 15mg 28tk; 15mg 30tk

Eesti - eesti - Ravimiamet

pharmaceutical works polpharma s.a. - olansapiin - suus dispergeeruv tablett - 20mg 30tk; 20mg 56tk; 20mg 28tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

teva pharma b.v.  - budesonide, formoterol fumarate dihydrate - asthma; pulmonary disease, chronic obstructive - ravimid hingamisteede obstruktiivsete haiguste, - budesonide / formoterol teva pharma b. on näidustatud ainult 18-aastastel ja vanematel täiskasvanutel. asthmabudesonide/formoterol teva pharma b. on näidustatud regulaarne astma raviks, kui kasutada kombinatsiooni (inhaleeritava kortikosteroidi ja pika toimeajaga β2 adrenoceptor agonist) on asjakohane:-patsientidel ei ole piisavalt kontrollitud inhaleeritava kortikosteroide ja "nii nagu vaja" sisse hingata lühikese toimeajaga β2 adrenoceptor agonistid. või-patsientidel, juba piisavalt kontrollitud, nii inhaleeritava kortikosteroide ja pika toimeajaga β2 adrenoceptor agonistid. copdsymptomatic patsientide ravi copd koos forced expiratory volume in 1 sekundi jooksul (fev1) .

Euroopa Liit - eesti - EMA (European Medicines Agency)

taw pharma (ireland) limited - klopidogreelvesinikkloriid - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombootilised ained - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Euroopa Liit - eesti - EMA (European Medicines Agency)

1 a pharma gmbh - rivastigmiin - alzheimer disease; dementia; parkinson disease - psychoanaleptics, - kerge kuni mõõdukalt raskekujulise alzheimeri tõve sümptomaatiline ravi. sümptomaatiline ravi kerge kuni mõõdukalt raske dementsuse patsientidel, kellel on idiopaatiline parkinsoni tõbi.

Eesti - eesti - Ravimiamet

pharmaceutical works polpharma s.a. - metoprolool - toimeainet prolongeeritult vabastav tablett - 50mg 28tk; 50mg 60tk; 50mg 14tk; 50mg 56tk; 50mg 10tk

Eesti - eesti - Ravimiamet

pharmaceutical works polpharma s.a. - metoprolool - toimeainet prolongeeritult vabastav tablett - 200mg 30tk; 200mg 56tk; 200mg 20tk; 200mg 50tk; 200mg 14tk; 200mg 98tk; 200mg 28tk

Eesti - eesti - Ravimiamet

pharmaceutical works polpharma s.a. - metoprolool - toimeainet prolongeeritult vabastav tablett - 25mg 10tk; 25mg 98tk; 25mg 100tk; 25mg 20tk; 25mg 28tk; 25mg 14tk; 25mg 30tk

Eesti - eesti - Ravimiamet

pharmaceutical works polpharma s.a. - metoprolool - toimeainet prolongeeritult vabastav tablett - 100mg 60tk; 100mg 20tk; 100mg 10tk; 100mg 30tk; 100mg 100tk; 100mg 14tk; 100mg 56tk; 100mg 28tk; 100mg 98tk

Eesti - eesti - Ravimiamet

pharmaceutical works polpharma s.a. - orlistaat - kõvakapsel - 60mg 42tk; 60mg 60tk; 60mg 84tk